Albert Grinshpun

19PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 15, 2026
Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

|Jun 26, 2026
A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor-Positive Metastatic Breast Cancer.

|Jan 09, 2026
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management.

Adar Yaacov, Roni Gillis, Jaber Salim

|Jun 08, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.

Albert Grinshpun, Douglas Russo, Wen Ma

|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.

Cristina Guarducci, Agostina Nardone, Douglas Russo

|May 24, 2023
Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer.

Stefania Morganti, Heather A Parsons, Nancy U Lin

Pageof 4

Frequent Collaborators

5 joint publications

Aviad Zick

4 joint publications

Jonathan E Cohen

4 joint publications

Rinath Jeselsohn

3 joint publications

Ronen Sadeh